Home / Stocks / IDXX

IDEXX Laboratories (IDXX, Health Care Equipment) Stock Valuation & Fair Value Poor on forward returns

IDEXX Laboratories (IDXX, Health Care Equipment) trades at a blended P/E of 36.0, about 12% below its historical normal valuation, with a forward growth estimate of 13.0% and a PEG of 2.76. Analysts' one-year estimates have been hit 45% of the time. Priced at its historical normal P/E of 40.9 on the same blended earnings, the 2026-10-02 close of $518.39 corresponds to about $589 a share. This is a valuation reference, not a price target.

DATA AS OF 2026-10-05
Blended P/E
36.0
Normal P/E
40.9
PEG
2.76
Fwd growth
13.0%
Div yield
0.0%
RSI (14)
43.9
Neutral
Technical context
  • Price $513.14 at the 2026-10-08 close, 0.7% below the 20-day average ($516.57) and 5.0% below the 50-day ($540.25).
  • RSI (14) at 43.9.
  • 52-week range $504.70 to $766.68: the price is 33.1% below the high and 1.7% above the low.

The Street vs SeerForecast

Wall Street's mean price target for IDXX is $701.33 across 12 analysts, 36.7% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: poor on forward returns. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been poor on forward returns since 2026-06-10.

Blended P/E and rating by weekBlended P/E moved from 40.8 to 36.0 between 2026-06-10 and 2026-10-02, against a normal P/E of 40.9, with 0 rating changes over 36 recorded weeks.2026-06-10: P/E 40.8, Poor on forward returns, recalculated for the week of 2026-06-102026-06-12: P/E 40.8, Poor on forward returns, recalculated for the week of 2026-06-142026-06-16: P/E 40.8, Poor on forward returns, recalculated for the week of 2026-06-162026-06-18: P/E 40.8, Poor on forward returns, recalculated for the week of 2026-06-212026-07-02: P/E 38.7, Poor on forward returns, recalculated for the week of 2026-07-022026-07-06: P/E 40.2, Poor on forward returns, recalculated for the week of 2026-07-062026-07-09: P/E 40.2, Poor on forward returns, recalculated for the week of 2026-07-092026-07-10: P/E 40.5, Poor on forward returns, recalculated for the week of 2026-07-122026-07-13: P/E 40.5, Poor on forward returns, recalculated for the week of 2026-07-132026-07-14: P/E 40.5, Poor on forward returns, recalculated for the week of 2026-07-142026-07-20: P/E 40.7, Poor on forward returns, recalculated for the week of 2026-07-202026-07-22: P/E 40.7, Poor on forward returns, recalculated for the week of 2026-07-222026-07-24: P/E 38.9, Poor on forward returns, recalculated for the week of 2026-07-252026-07-27: P/E 38.9, Poor on forward returns, recalculated for the week of 2026-07-272026-07-31: P/E 39.9, Poor on forward returns, recalculated for the week of 2026-07-312026-07-31: P/E 39.9, Poor on forward returns, recorded live 2026-08-032026-08-07: P/E 41.8, Poor on forward returns, recalculated for the week of 2026-08-072026-08-07: P/E 41.5, Poor on forward returns, recorded live 2026-08-102026-08-14: P/E 40.0, Poor on forward returns, recalculated for the week of 2026-08-142026-08-14: P/E 40.0, Poor on forward returns, recorded live 2026-08-172026-08-21: P/E 38.4, Poor on forward returns, recalculated for the week of 2026-08-212026-08-21: P/E 39.2, Poor on forward returns, recorded live 2026-08-242026-08-27: P/E 39.2, Poor on forward returns, recalculated for the week of 2026-08-272026-08-28: P/E 38.3, Poor on forward returns, recalculated for the week of 2026-08-282026-08-28: P/E 39.0, Poor on forward returns, recalculated for the week of 2026-08-302026-08-28: P/E 39.0, Poor on forward returns, recorded live 2026-08-312026-09-04: P/E 37.5, Poor on forward returns, recalculated for the week of 2026-09-052026-09-04: P/E 37.5, Poor on forward returns, recorded live 2026-09-072026-09-11: P/E 35.3, Poor on forward returns, recalculated for the week of 2026-09-122026-09-11: P/E 35.3, Poor on forward returns, recorded live 2026-09-142026-09-18: P/E 35.7, Poor on forward returns, recalculated for the week of 2026-09-192026-09-18: P/E 35.7, Poor on forward returns, recorded live 2026-09-212026-09-25: P/E 36.1, Poor on forward returns, recalculated for the week of 2026-09-262026-09-25: P/E 36.1, Poor on forward returns, recorded live 2026-09-282026-10-02: P/E 36.0, Poor on forward returns, recalculated for the week of 2026-10-032026-10-02: P/E 36.0, Poor on forward returns, recorded live 2026-10-0536.038.040.0Jun 10Jul 8Aug 6Sep 4Oct 2Normal P/E 40.9
Poor on forward returns

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

Selected weeks: the first, the latest, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-06-10P/E 40.8-0%Poor on forward returns (recalculated)
2026-08-07P/E 41.8+2%Poor on forward returns (recalculated)
2026-09-12P/E 35.3-14%Poor on forward returns (recalculated)
2026-10-05P/E 36.0-12%Poor on forward returns ← now
Show all 36 weeks
WeekBlended P/EPremium to normal P/ERating
2026-06-10P/E 40.8-0%Poor on forward returns (recalculated)
2026-06-14P/E 40.8-0%Poor on forward returns (recalculated)
2026-06-16P/E 40.8-0%Poor on forward returns (recalculated)
2026-06-21P/E 40.8-0%Poor on forward returns (recalculated)
2026-07-02P/E 38.7-5%Poor on forward returns (recalculated)
2026-07-06P/E 40.2-2%Poor on forward returns (recalculated)
2026-07-09P/E 40.2-2%Poor on forward returns (recalculated)
2026-07-12P/E 40.5-1%Poor on forward returns (recalculated)
2026-07-13P/E 40.5-1%Poor on forward returns (recalculated)
2026-07-14P/E 40.5-1%Poor on forward returns (recalculated)
2026-07-20P/E 40.7-0%Poor on forward returns (recalculated)
2026-07-22P/E 40.7-0%Poor on forward returns (recalculated)
2026-07-25P/E 38.9-5%Poor on forward returns (recalculated)
2026-07-27P/E 38.9-5%Poor on forward returns (recalculated)
2026-07-31P/E 39.9-2%Poor on forward returns (recalculated)
2026-08-03P/E 39.9-2%Poor on forward returns
2026-08-07P/E 41.8+2%Poor on forward returns (recalculated)
2026-08-10P/E 41.5+2%Poor on forward returns
2026-08-14P/E 40.0-2%Poor on forward returns (recalculated)
2026-08-17P/E 40.0-2%Poor on forward returns
2026-08-21P/E 38.4-6%Poor on forward returns (recalculated)
2026-08-24P/E 39.2-4%Poor on forward returns
2026-08-27P/E 39.2-4%Poor on forward returns (recalculated)
2026-08-28P/E 38.3-6%Poor on forward returns (recalculated)
2026-08-30P/E 39.0-5%Poor on forward returns (recalculated)
2026-08-31P/E 39.0-5%Poor on forward returns
2026-09-05P/E 37.5-8%Poor on forward returns (recalculated)
2026-09-07P/E 37.5-8%Poor on forward returns
2026-09-12P/E 35.3-14%Poor on forward returns (recalculated)
2026-09-14P/E 35.3-14%Poor on forward returns
2026-09-19P/E 35.7-13%Poor on forward returns (recalculated)
2026-09-21P/E 35.7-13%Poor on forward returns
2026-09-26P/E 36.1-12%Poor on forward returns (recalculated)
2026-09-28P/E 36.1-12%Poor on forward returns
2026-10-03P/E 36.0-12%Poor on forward returns (recalculated)
2026-10-05P/E 36.0-12%Poor on forward returns ← now

Frequently asked questions

Is IDEXX Laboratories stock overvalued?

At a blended P/E of 36.0 versus its historical normal P/E of 40.9, IDEXX Laboratories trades about 12% below its typical valuation, with a PEG of 2.76 on 13.0% forward growth. tickerseer currently rates it poor on forward returns.

What is IDEXX Laboratories's fair value and PEG?

IDEXX Laboratories trades at a blended P/E of 36.0 against a historical normal P/E of 40.9, a PEG of 2.76, and a forward growth estimate of 13.0%. Priced at its historical normal P/E of 40.9 on the same blended earnings, the 2026-10-02 close of $518.39 corresponds to about $589 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of IDEXX Laboratories changed?

tickerseer's rating has been poor on forward returns since 2026-06-10.

What is the analyst price target for IDEXX Laboratories?

The mean Wall Street price target for IDEXX Laboratories is $701.33 across 12 analysts, 36.7% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Equipment. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track IDXX free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.